Financials

Discussions Technicals Seasonals

6976 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Acepodia, Inc. operates as a clinical-stage biotechnology company and it develops cell therapies to treat cancer. It designed enhanced cell therapy approaches by applying Antibody-Cell Conjugation (ACC), ?d2 T2, and oNK Cells technology. The company was founded by Patrick Yuhmin Yang and Hsiao Sonny on February 15, 2017 and is headquartered in New Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

6976 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company